Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
A review of vaccinology and ex vivo antigen-loaded dendritic cells: A different approach to infectious disease vaccines.
Journal: Human vaccines & immunotherapeutics
Published: November 21, 2025
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.
Journal: Human vaccines & immunotherapeutics
Published: September 12, 2025
Next-generation vaccines are showing promise against glioblastoma.
Journal: Oncotarget
Published: August 05, 2024
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines.
Journal: Human vaccines & immunotherapeutics
Published: May 03, 2023
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 29, 2022
A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses.
Journal: Human vaccines & immunotherapeutics
Published: August 26, 2022
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Journal: Journal for immunotherapy of cancer
Published: April 01, 2020
Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial.
Journal: Journal of translational medicine
Published: January 22, 2020
Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine.
Journal: Human vaccines & immunotherapeutics
Published: October 19, 2019
Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment.
Journal: Biomedicines
Published: September 03, 2019
Last Updated: 09/26/2026